Eli Lilly to Buy Morphic Holding for $3.2 Billion
Wall Street Journal
Eli Lilly has agreed to buy biopharmaceutical company Morphic Holding for $3.2 billion in a deal that bolsters the drugmaker’s immunology pipeline.
https://www.wsj.com/articles/eli-lilly-to-buy-morphic-holding-for-3-2-billion-b68638d2